NZ598438B - Adhesive bandage - Google Patents
Adhesive bandage Download PDFInfo
- Publication number
- NZ598438B NZ598438B NZ598438A NZ59843812A NZ598438B NZ 598438 B NZ598438 B NZ 598438B NZ 598438 A NZ598438 A NZ 598438A NZ 59843812 A NZ59843812 A NZ 59843812A NZ 598438 B NZ598438 B NZ 598438B
- Authority
- NZ
- New Zealand
- Prior art keywords
- absorbent pad
- bandage
- channels
- pad
- regions
- Prior art date
Links
- 239000000853 adhesive Substances 0.000 title claims abstract description 64
- 230000001070 adhesive Effects 0.000 title claims abstract description 64
- 230000002745 absorbent Effects 0.000 claims abstract description 131
- 239000002250 absorbent Substances 0.000 claims abstract description 131
- 210000003491 Skin Anatomy 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 206010049796 Excoriation Diseases 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 4
- 229920002994 synthetic fiber Polymers 0.000 claims description 2
- 200000000019 wound Diseases 0.000 description 39
- 239000002585 base Substances 0.000 description 38
- -1 polyethylene Polymers 0.000 description 37
- 206010052428 Wound Diseases 0.000 description 33
- 239000012530 fluid Substances 0.000 description 17
- 239000002674 ointment Substances 0.000 description 16
- 229920000139 polyethylene terephthalate Polymers 0.000 description 15
- 239000000463 material Substances 0.000 description 14
- 229920001155 polypropylene Polymers 0.000 description 12
- 239000007788 liquid Substances 0.000 description 10
- 239000004743 Polypropylene Substances 0.000 description 9
- 238000004049 embossing Methods 0.000 description 9
- 210000004369 Blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000001814 pectin Substances 0.000 description 6
- 229920001277 pectin Polymers 0.000 description 6
- 235000010987 pectin Nutrition 0.000 description 6
- 239000004698 Polyethylene (PE) Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000000416 hydrocolloid Substances 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 210000001124 Body Fluids Anatomy 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- 210000000416 Exudates and Transudates Anatomy 0.000 description 3
- 210000003284 Horns Anatomy 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000000280 densification Methods 0.000 description 3
- 239000003974 emollient agent Substances 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 238000010191 image analysis Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000001736 Capillaries Anatomy 0.000 description 2
- 208000008313 Contusions Diseases 0.000 description 2
- 206010022114 Injury Diseases 0.000 description 2
- 240000004119 Melissa officinalis Species 0.000 description 2
- 235000010654 Melissa officinalis Nutrition 0.000 description 2
- 229940029983 VITAMINS Drugs 0.000 description 2
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000000844 anti-bacterial Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 150000004676 glycans Polymers 0.000 description 2
- 239000000865 liniment Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000006011 modification reaction Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Polymers 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamins Natural products 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- FTALTLPZDVFJSS-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl prop-2-enoate Chemical compound CCOCCOCCOC(=O)C=C FTALTLPZDVFJSS-UHFFFAOYSA-N 0.000 description 1
- SFPNZPQIIAJXGL-UHFFFAOYSA-N 2-ethoxyethyl 2-methylprop-2-enoate Chemical compound CCOCCOC(=O)C(C)=C SFPNZPQIIAJXGL-UHFFFAOYSA-N 0.000 description 1
- HFCUBKYHMMPGBY-UHFFFAOYSA-N 2-methoxyethyl prop-2-enoate Chemical compound COCCOC(=O)C=C HFCUBKYHMMPGBY-UHFFFAOYSA-N 0.000 description 1
- 229940035676 ANALGESICS Drugs 0.000 description 1
- 229940035674 ANESTHETICS Drugs 0.000 description 1
- 240000004507 Abelmoschus esculentus Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 240000005513 Aloe vera Species 0.000 description 1
- 229940061720 Alpha Hydroxy Acids Drugs 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940064004 Antiseptic throat preparations Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 229960000686 Benzalkonium Chloride Drugs 0.000 description 1
- 229960005274 Benzocaine Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N Benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N Capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 229960004830 Cetylpyridinium Drugs 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000005497 Cyamopsis tetragonoloba Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Exidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 229940076493 Exidine Drugs 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 229910000760 Hardened steel Inorganic materials 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N Heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960002897 Heparin Drugs 0.000 description 1
- 239000004831 Hot glue Substances 0.000 description 1
- 229960004873 LEVOMENTHOL Drugs 0.000 description 1
- 208000002473 Lacerations Diseases 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N Maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 229940041616 Menthol Drugs 0.000 description 1
- 229960003377 Metandienone Drugs 0.000 description 1
- XWALNWXLMVGSFR-HLXURNFRSA-N Methandrostenolone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 XWALNWXLMVGSFR-HLXURNFRSA-N 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N Methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N Neomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 229940053050 Neomycin Sulfate Drugs 0.000 description 1
- 229940049964 Oleate Drugs 0.000 description 1
- 229920000805 Polyaspartic acid Polymers 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229960003548 Polymyxin B Sulfate Drugs 0.000 description 1
- 229920001451 Polypropylene glycol Polymers 0.000 description 1
- DQKXQSGTHWVTAD-UHFFFAOYSA-N Pramocaine Chemical compound C1=CC(OCCCC)=CC=C1OCCCN1CCOCC1 DQKXQSGTHWVTAD-UHFFFAOYSA-N 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N Retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N Silver sulfadiazine Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- NWGKJDSIEKMTRX-MDZDMXLPSA-N Sorbitan oleate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(O)C1OCC(O)C1O NWGKJDSIEKMTRX-MDZDMXLPSA-N 0.000 description 1
- 229950004959 Sorbitan oleate Drugs 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229960002372 Tetracaine Drugs 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N Tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- JIVZKJJQOZQXQB-UHFFFAOYSA-N Tolazoline Chemical compound C=1C=CC=CC=1CC1=NCCN1 JIVZKJJQOZQXQB-UHFFFAOYSA-N 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- 229960001727 Tretinoin Drugs 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 229920001567 Vinyl ester Polymers 0.000 description 1
- 229940046009 Vitamin E Drugs 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Xylocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- OJYLAHXKWMRDGS-UHFFFAOYSA-N Zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N all-trans-retinaldehyde Chemical compound O=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 230000003444 anaesthetic Effects 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000845 anti-microbial Effects 0.000 description 1
- 230000001139 anti-pruritic Effects 0.000 description 1
- 230000002421 anti-septic Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 229930003833 capsaicin Natural products 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical compound CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- VGYFVNQYBUPXCQ-UHFFFAOYSA-N ethene;2-methyloxirane Chemical compound C=C.CC1CO1 VGYFVNQYBUPXCQ-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxyl anion Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M laurate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-M oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC([O-])=O ZQPPMHVWECSIRJ-KTKRTIGZSA-M 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001888 polyacrylic acid Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960001896 pramocaine Drugs 0.000 description 1
- 229940093883 pramoxine Drugs 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 229960002312 tolazoline Drugs 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000000261 vasodilator Effects 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0203—Adhesive plasters or dressings having a fluid handling member
- A61F13/0206—Adhesive plasters or dressings having a fluid handling member the fluid handling member being absorbent fibrous layer, e.g. woven or nonwoven absorbent pad, island dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0203—Adhesive plasters or dressings having a fluid handling member
- A61F13/0223—Adhesive plasters or dressings having a fluid handling member characterized by parametric properties of the fluid handling layer, e.g. absorbency, wicking capacity, liquid distribution
Abstract
Patent 598438 An adhesive bandage has a backing layer with an absorbent pad attached to it with adhesive. The pad has raised tufted regions separated by lower channel regions of a greater density than the raised regions. Each of the tufted regions is not a polygon of four to eight sides.
Description
Received by IPONZ 25 June 2012
NEW ZEALAND
PATENTS ACT, 1953
COMPLETE SPECIFICATION
ADHESIVE E
We, jOHNSON &]OHNSON CONSUMER COMPANIES, INC, a corporation of the State
of Newjersey, United States of America, of Grandview Road, Skillman, New Jersey 08558,
United States of America, do hereby declare the invention for which we pray that a patent may be
granted to us, and the method by which it is to be performed, to be ularly described in and
by the following statement:
Received by IPONZ 25 June 2012
ADHESIVE BANDAGE
FIELD OF THE INVENTION
The present invention relates to an adhesive e to be applied onto the skin,
particularly an ve bandage with an absorbent pad having tufied regions
surrounded and separated by a network of interconnecting channels recessed in the
surface of the absorbent pad.
BACKGROUND OF THE INVENTION
There are many types of wounds to the human body. They may be open or
. Open wounds include incisions or incised wounds, lacerations, abrasions,
puncture wounds and penetration wounds. Closed wounds include contusions (bruises),
mas and crushing injuries. Depending on the severity of the wound, certain
wounds may require g via sutures and the like, followed by l application of
a wound dressing to protect the wound from dirt and further damage by contact.
Similarly, wounds due to medical surgical procedures typically require application of a
wound dressing subsequent to surgery to t the wound.
As there are different types of wounds to the body, so are there different types
of dressings for application to such wounds. In certain dressings, absorbent structures,
e. g. pads, may be used to absorb exudates fiom the wound. Other wound dressings may
be free of such absorbent pads. For e, US 3,053,252 discloses bandages where
non—absorbent support surfaces or edges project beyond the absorbent surface towards
the wound site to form an embossed pattern of absorbent areas and non-absorbent
support surfaces. US 4,781,710 discloses bandages that utilize pads having tufted
regions nded by channels. The channels require both a transport region and a
storage region, where density of the ort region is greater than that of the storage
region. US 4,259,387 relates to absorbent products adapted to absorb body fluids. Such
ts utilize a loosely compacted osic fibrous batt having a plurality of spaced,
relatively narrow, dense lines in the general plane of the batt. The batts have a non-
uniform density where the areas of the batt adjacent the lines cover or obscure the lines
ed by IPONZ 25 June 2012
due to modified batt regions of lesser density adjacent the lines than the average density
ofthe batt.
SUMMARY OF THE INVENTION
The present invention s to bandages for application to abrasions or cuts in
the skin, where the bandage includes a backing layer having a first surface and a second
surface opposite the first surface; and an absorbent pad associated with the backing
layer. The absorbent pad es a first e facing the g layer and that has a
first e area, and a second surface opposite the first surface and that has a second
surface area. The absorbent pad comprises a plurality of tufted regions surrounded and
separated by a first k of interconnecting channels ed in the second surface
of the absorbent pad. The channels comprise and are defined by channel sidewalls
extending away from the second surface and into the core body ofthe absorbent pad
and terminating in a first surface of a channel base region extending between the
channel sidewalls. The absorbent pad has a thickness defined by the distance between
the first and second surfaces of the absorbent pad. The tufted regions have a
substantially m first density, while the channel base region has a substantially
uniform second density that is greater than the ntially uniform first density of the
tufted regions. The channel base region has a thickness defined by the distance between
the first surface of the channel base region and a second surface of the channel base
region opposite the first surface. The network of interconnecting channels is visible to
the user of the bandages.
Accordingly, in a first aspect the invention provides an ve bandage for
application to abrasions or cuts in the skin, comprising:
a backing layer comprising a first surface and a second surface opposite said
first surface;
an adhesive layer applied to at least a portion of said second surface of said
backing layer; and
an absorbent pad associated with said backing layer, said ent pad
comprising,
a first surface facing said second surface of said backing layer and having a
first surface area,
ed by IPONZ 25 June 2012
a second surface opposite said first surface and having a second surface
area; and
a core body bounded by said first and second surfaces;
said absorbent pad comprising a plurality of tufted s surrounded and
separated by a first network of interconnecting channels recessed in said second
surface of said absorbent pad, said ls comprising channel sidewalls
extending away from said second surface of said absorbent pad and into said
core body of said absorbent pad and terminating in a first surface of a channel
base region extending between said channel sidewalls;
wherein the absorbent pad is free of slits or perforations uniformly buted
throughout the absorbent pad that would allow the adhesive layer to contact the wound
surface;
wherein said tufted regions have a substantially uniform first density, said channel base
region has a substantially uniform second y greater than said substantially
uniform first density of said tufted regions and said network of interconnecting
ls is Visible; and with the o that the shape of each of the tufted regions is
not a polygon having from four to eight sides.
BRIEF DESCRIPTION OF THE DRAWINGS
The present invention will now be bed in greater detail with reference to
embodiments ented in the drawings.
is a perspective View of an embodiment of an ve bandage of the
present invention;
is a cross-sectional View of the adhesive bandage illustrated in
taken along line 2a~——2a;
is a cross—sectional side View of an adhesive bandage similar to the
bandage as shown in where the second surface of the absorbent pad comprises a
covering layer;
is a View of a first embodiment of the absorbent pad depicted in
taken perpendicular to the second surface of the bandage;
Received by IPONZ 25 June 2012
is a cross-sectional side view taken along line 3b—--3b of the pad
embodiment illustrated in ;
is a cross-sectional side View of a second embodiment of an absorbent
pad used in bandages of the present invention;
is a cross—sectional side View of one embodiment of a bandage
ing to the t ion utilizing the absorbent pad depicted in ;
is a cross—sectional side View of another embodiment of a bandage
ing to the present invention utilizing the absorbent pad depicted in ;
is a perspective view of the bandage depicted in as seen from
the first side of the backing layer of the bandage;
is a View of another embodiment of an absorbent pad used in bandages
ofthe present invention;
is a sectional side View of another embodiment of an ve
bandage ofthe present invention; and.
is a view of another embodiment of an absorbent pad used in bandages
of the present invention.
DETAILED DESCRIPTION OF THE INVENTION
Bandages according to the present invention include a backing layer having a
first surface facing away from the skin and a second surface, opposite the first surface,
and facing the skin. The backing layer may have various shapes, e. g. rectangular,
, oval, circular, ovoid, oblong, etc. The shape of the bandage is defined by the
shape ofthe backing layer. The backing layer may be thin, highly e or
deformable, impervious, and clear or opaque. In general, the backing s
thickness should fall within the range of 0.05 to 0.20 millimeter to achieve the forming
and flexing characteristics desired.
A polyethylene film may be used as the backing layer, and particularly effective
results may be achieved with stretchable, elastomeric films formed ofpolyurethane,
which has the further advantage of gas (including water vapor) transmissibility. It is to
be understood, however, that other flexible, water insoluble polymeric films known in
ed by IPONZ 25 June 2012
the art may be used. Furthermore, the g layer may be formed from closed-cell
polymeric foam, particularly one with an integral skin covering the side facing away
from the skin of the user. Foam layers formed ofpolyurethane or polyethylene are
suitable, while other ric foams having similar properties may be used. In
addition, the backing layer may be made from other polyolefins, vinyl polyethylene
acetate, textile non-woven fabrics, rubber, or other materials known in the bandage art.
rs used to make backing layers used in bandages of the present invention may
t Viscosity of about 500 to 500,000 centipoises at temperatures of about 190°C, or
about 1,000 to 30,000 centipoises at temperatures of about 190°C, or about 3,000 to
15,000 centipoises at temperatures of about 190°C. The backing layer may be
impermeable to liquid, but permeable to gas, which allows the wound and the skin to
which the bandage of the present invention is adhered to breathe. In one embodiment,
the backing layer may have pores of such a size that will allow only the passage of
gases, which have molecules of extremely small size. Finally, one can conceive of a
backing layer that is perforated for more ventilation of the skin. Perforations may be
circular in area and have a range of diameters, such as from about 0.1 to about 0.8
eters. However, the backing layer may be totally impermeable to gases, when
necessary.
Bandages ofthe present invention comprise an absorbent pad associated with
the backing layer. As used herein, “associated with the backing layer” means that the
absorbent pad is affixed either directly or indirectly to the backing layer so that it will
not become separated fiom the backing layer during normal use. Association may be
accomplished by applying an adhesive layer between the second surface ofthe backing
layer and first surface of the absorbent pad, thereby adhesively bonding the absorbent
pad directly to the backing layer. The absorbent pad also may be associated with an
intermediate layer, which in turn is associated with the backing layer, thus indirectly
ating the absorbent pad to the backing layer via the intermediate layer.
Association also may be accomplished by other known means such as ultrasonic
welding.
The ent pad includes a first e facing the second surface of the
g layer, and that has a first surface area, and a second e opposite the first
e and facing the skin, and that has a second surface area. The absorbent pad used
in bandages ofthe present invention may have various shapes, e.g. rectangular, square,
Received by IPONZ 25 June 2012
oval, circular, ovoid, oblong, etc., and is sized to cover less area than the backing layer
so that, in use, the adhesive layer on the g layer is in contact with the user’s skin,
but preferably does not contact the wound surface. As can be seen in s 1-6, the
absorbent pad is free of slits or perforations mly distributed throughout the
absorbent pad that would allow the adhesive layer to t the wound surface. In
certain embodiments, the absorbent pad is free of slits or perforations that would allow
the adhesive layer to contact the wound surface. The absorbent pad may be a fibrous
matrix comprising materials ed from the group consisting of s, yarns, nets,
laces, felts and ens. The basis weight ofthe materials selected as the ent
pad in bandages of the present invention may be any of those used conventionally to
make absorbent pads for bandages utilized in applications similar to those of the
present invention. For example, the basis weight of the material may be from about 3.0
oz/yd2 to about 5.5 oz/ydz, although the invention is not limited as such.
The absorbent pad may be made from any type of material cormnonly used in
the art in forming such pads for use in bandages. Materials that may be used include
cellulose fiber gauzes, lightly cross—linked tissue structures, and other fibrous pads
comprising natural or synthetic materials such as cotton, polyethylene terepthalate
(PET), polypropylene (PP), or blends of viscose rayon and polyolefins, or other
materials that are absorbent and that are capable ofbeing embossed to form the network
of interconnecting channels recessed in the surface of the absorbent pad. In certain
embodiments, the absorbable pad is not degradable in water.
The absorbent pad comprises a plurality of tufted regions surrounded and
separated by a first k of interconnecting channels recessed in the second surface
of the absorbent pad. Tufted s are understood to be substantially undensified, i.e.
relatively low density regions compared to the density of the channel base regions. The
term “channels” refers to those recessed s which separate and surround the tufted
regions. The first and second surfaces ofthe tufted regions are coincident with the first
and second surfaces of the absorbent pad, respectively. The ent pad has a
thickness defined by the maximum distance between the first and second surfaces of
the absorbent pad. Typically, the thickness of the absorbent pad may range from about
0.3 millimeters to about 2.5 millimeters.
The interconnecting channels recessed in the second surface of the absorbent
pad comprise and are defined by channel lls extending away from the second
Received by IPONZ 25 June 2012
surface and into the core body of the absorbent pad and terminating in a first surface of
a channel base region extending between the channel sidewalls. The channel base
region fiirther has a second surface opposite the first surface, and a ess defined by
the distance between the first and second surfaces of the channel base region. In certain
embodiments, a second network of interconnecting channels is recessed into the first
e of the absorbent pad. The second network of onnected channels may be in
alignment with the first network of interconnecting channels found in the second
surface ofthe ent pad. The channels in the first surface of the absorbent pad
se and are defined by channel sidewalls extending away from the first e
and into the core of the absorbent pad and terminating in the second surface of the
channel base region, which s between the channel sidewalls in the first surface of
the absorbent pad.
The tufted regions have a substantially uniform first density. By “substantially
uniform first density”, it is meant that the density of the tufted region adjacent the
channels is ntially the same as the average density of the tufted region across the
entire area of the tufted region, such that the channels are not obscured by the tufted
region adjacent the channel. The channel base region has a substantially uniform
second y that is greater than the substantially uniform first density of the tufted
regions. By “substantially uniform second density”, it is meant that the density of the
channel base regions is substantially the same throughout the channel base . In
some embodiments, the second density ofthe channel base region is about 12 times or
less greater than the first density of the tufted region, or from 1.1 to about 10 times
greater than the y of the tufted regions. In some embodiments, the substantially
uniform first density of the tufted regions is from about 0.082 grams/cubic centimeter
to about 0.17 grams/cubic centimeter. In some embodiments, the substantially uniform
second density of the l base regions is from about 0.11 grams/cubic centimeter
to about 0.96 cubic centimeter. The network of recessed, interconnecting
channels may comprise from about 5 to about 20 percent of the surface area of the
surface of the absorbent pad, or from about 10 to about 15 percent of the surface area of
the surface of the absorbent pad. This is whether the channels are present on one
surface or both es of the pad.
The shape of each of the tufted regions of the absorbent pads of the bandages
claimed herein is other than a polygon having from four to eight sides. In some
ed by IPONZ 25 June 2012
embodiments, the shape of each of the tufted s is polygonal, ical, ovoid or
circular.
However, tufied regions in the shape of a polygon having four to eight sides are
also described herein. This information is retained for technical information.
The thickness of the channel base region may vary from about 0.1 millimeters
to about 1.5 millimeters, depending on the depth of the channels and whether both
surfaces or only one surface of the absorbent pad comprise channels recessed therein.
In addition to the substantially m first density of the tufied regions, the channels
have a width and depth such that the network of interconnecting channels is Visible to
the user. By “visible”, it is meant that the network of interconnecting channels is
distinguishable from the tufted s when the bandage is observed by the user at
distances normally encountered when applying the bandage to the skin or wound, e.g.
from about 6 to about 24 , or from about 6 to about l2 inches.
Interconnecting channels in the absorbent pad serve a number of functions.
Interconnecting channels function to transport low Viscosity fluid, e. g. wound es,
away from the wound surface by wicking action. As used herein, low viscosity fluids
are those with viscosities of less than 50,000 centipoises. The channel base s, due
to their high density ve to the tufied regions, have smaller capillaries between their
fibers and are not able to absorb as much fluid as the lower density tufted regions.
Thus, channel base regions provide relatively fast wicking.
The tufted regions have a density less than the density of the channel base
regions and, therefore, have larger capillaries between their fibers than the channel base
regions. This gives the tufted regions the cy to absorb more liquid than the
channel base regions. In use, low viscosity liquid which is deposited onto the absorbent
pad is absorbed to some degree by the tufied regions. In bandages of the present
invention, tufted regions adjacent to the area where the low Viscosity liquid is deposited
may not be able to absorb all liquid fast enough to prevent “puddling” of the liquid on
the ent pad, which resultantly may give the user an uncomfortably wet feeling or
cause skin irritation. The excess liquid may enter the interconnecting channels, which
may then direct the liquid to other tufted regions of the absorbent pad that may be less
saturated, such that they will accept and absorb the excess low viscosity liquid.
Another function of the interconnecting channels is to serve as a storage depot
for high viscosity fluids. As used herein, high viscosity fluids are those with viscosities
Received by IPONZ 25 June 2012
of greater than 50,000 centipoises. If a user places a high viscosity ointment, balm,
emollient, t, cream or salve on the wound site, and then places a rd pad
with a uniform density hout its structure in contact with the high viscosity fluid,
the fluid may spread from the wound site to portions of the pad that do not cover the
wound. If, however, a user places a high viscosity ointment, balm, emollient, unguent,
cream or salve on the wound site, and then places bandages of the present ion in
contact with the high viscosity fluid, the fluid may flow from the lower density tufted
regions to the relatively higher density channel base regions in the interconnecting
channels. In this way, the high viscosity fluid may be maintained at the site of the
wound.
Yet another function ofthe k of interconnecting channels is to provide a
visual cue to the user. The term “visual cue”, as used herein, refers to visual
information, e.g. the way a product or portion of a product appears to the user, which is
used in connection with identifying a function or functions of the product. With respect
to bandages ofthe present invention, the visual cue is as to the on of the channels
in transporting low viscosity fluid away from the wound surface by wicking action,
and/or in serving as a storage depot for high viscosity fluids. Accordingly, the network
of interconnecting ls is e, as defined above. In some embodiments, the
width ofthe channels is from about 0.2 millimeters to about 0.6 millimeters or from
about 0.3 millimeters to about 0.45 eters, and the depth is from about 0.02 to
about 2.0 millimeters, or from about 0.04 to about 1.1 millimeters. In certain
embodiments, at least the first network of interconnecting channels recessed in the
second surface of the absorbent pad is visible to the user when observed from the
second surface of the absorbent pad. In other embodiments, both first and second
networks of interconnecting channels recessed in the first and second surfaces of the
ent pad, respectively, are visible to the user when observed from the respective
surface. In one embodiment, the second network of onnecting channels recessed
in the first surface of the absorbent pad may be visible to the user through the backing
layer, where the backing layer is transparent or translucent. In another embodiment, the
backing layer may conform to the network of interconnecting channels due to the
process for making the e. In this embodiment, the backing layer itself comprises
the network of onnecting channels recessed in the first surface of the backing
layer, as shown herein.
Received by IPONZ 25 June 2012
In certain embodiments of the present invention the bandage may r
comprise an intermediate layer disposed between the backing layer and the absorbent
pad. The intermediate layer typically may be used where the backing layer is
transparent or translucent. In such bandages, the intermediate layer may be of a color
r to skin of the user and may be used to mask the appearance of the absorbent pad
to the user, which pad may include exudates from the wound, including blood. When
used, such intermediate layers may be made from materials known to those skilled in
the art for similar use. The intermediate layer can be made from any type of material
commonly used in the art in fonning adhesive bandages. In some embodiments, the
intermediate layer can be made from, for example, plastic netting materials such as
those sold under the tradename Delnet, available from Delstar Technologies, Inc.,
Middletown, DE.
In certain ments of the present invention, the second surface, ie. the
skin~facing e, of the absorbent pad comprises a covering layer affixed thereto.
When present, the ng layer is considered as an integral component of the second
surface of the absorbent pad and the k of interconnected channels is embossed
into the absorbent pad after application of the covering layer to the absorbent pad. As
such, the covering layer also comprises the network of interconnecting channels
recessed in the skin-facing e. The covering layer provides additional protection to
the wound and, where the ent pad is fibrous, prevents fibers from sticking to the
wound or obscuring the channels. The covering layer is permeable to es to allow
passage of the exudates from the wound to the ent pad. Thus, the covering layer
may e perforations. The covering layer may be made of, for example, plastic
netting materials such as those sold under the tradename Delnet, available from Delstar
Technologies, Inc., Middletown, DE.
In general, any of a variety of pressure-sensitive adhesives can be utilized in the
present ion as the adhesive layer to bond the absorbent pad to the backing layer
and to adhere the e to the skin. In ular, pressure-sensitive adhesives that
are biocompatible with human skin are typically utilized. Moreover, an adhesive used
in the present invention may be either generally water soluble, or generally insoluble or
dispersible in an aqueous environment. For instance, one commercially available
dispersible pressure—sensitive adhesive is sold under the trade name of HL—94l S—X and
is available from H.B. Fuller y. Another suitable adhesive includes about 10-
Received by IPONZ 25 June 2012
75% by weight of a polyalkyloxazoline polymer, 10-75% by weight of a functional
t comprising a hydroxy compound or a carboxylic acid compound, and 5-50% by
weight of a tackifier.
The water-dispersible ric component can include, for example,
surfactants such as poly(ethylene oxide) alkylphenyl , such as those sold under
the trade names IGEPALCO and IGEPAL.CA (available from Rhone—Poulenc, Inc.);
poly(ethylene oxide) lauryl, cetyl, and oleyl ethers such as those sold under the trade
name BRIJ (available from ICI Americas, Inc.); poly(ethylene oxide) laurate;
poly(ethylene oxide) oleate; sorbitan oleate; ethylene propylene oxide block
copolymers such as those sold under the trade names PLURONIC and TETRONIC
(available from BASF Corporation); and organic ate esters, such as those sold
under the trade name GAFAC PE-SlO (available from International Specialty
Products). Examples of other components include, but are not limited to, poly(acrylic
acid); poly(vinyl alcohol); —vinyl pyrrolidone); poly(acrylamide);
poly(alkoxyalkyl (meth)acrylates), such as 2—ethoxy ethyl te, 2-ethoxy ethyl
methacrylate, 2—(2—ethoxyethoxy) ethyl acrylate, and 2-methoxy ethyl acrylate
(available from SARTOMER Company, Inc.); poly(vinyl methyl ether); poly(vinyl
methyl ether: maleic anhydride), sold under the trade name GANTREZ (available from
International lty Products); poly(ether polyols), such as poly(propylene glycol)
and the like, such as those sold under the trade name SANNIX able from Sanyo
Chemical ries); copolymers f, and the like. Copolymers of these and alkyl
(meth)acrylate esters or vinyl esters are also suitable. Gums such as those derived from
okra and guar may also be used.
Still another suitable pressure—sensitive adhesive includes about 10% to about
80%, by weight, of an alkali e polymer; about 0 to about 30%, by weight, of a
poly(vinyl methyl ether); about 30% to about 70%, by weight, of a tackifying resin; and
about 5% to about 30%, by weight, of a suitable plasticizer. Still other examples of
suitable adhesives include HX 923 6—01 or HX 9237—01 hot melt adhesives, which are
obtainable from ATO Findley, Inc.
The adhesive layer used in the present invention may comprise hydrocolloids.
The hydrocolloid element used may be any substance that exhibits good performance in
this utilization, as for example, sodium carboxymethylcellulose, pectin, xanthan gum,
Received by IPONZ 25 June 2012
polysaccharides, sodium or calcium alginates, chitosan, seaweed extract (cageenan),
polyaspartic acid, polyglutamic acid, hyaluronic acid or salts and derivatives thereof,
among others.
Hydrocolloids, just as sodium carboxymethylcellulose and pectin, among
others, are agents that form gels as soon as they come into contact with the bodily
fluids fiom the wound. When used in adhesive bandages, these hydrocolloids are
combined with elastomers and/or adhesives. Preferably, the adhesive bandage should
provide a humid environment suitable for acceleration of the healing, but without
saturation or cicatrisation.
Pectin is a complex-structure polysaccharide ted from vegetable s,
for example, peels from citric fruits or apple pulp, which has a highly hydrophilic
structure. As a result, pectin associates easily with the water les of the bodily
fluids from the wound, forming a viscous gel on the injury bed. Its chemical similarity
with alginates causes the physical properties of absorption and gel formation to
resemble each other.
ymethylcellulose, in turn, is a ose derivative formed by reaction of
cellulose with s, such as, for example, sodium, potassium, calcium, etc,
hydroxide. It is the nature of combined alkali that imparts the ionic characteristic of
carboxymethylcellulose. When sodium hydroxide is used, sodium
carboxymethylcellulose is formed. Just as in the case of pectin, carboxymethylcellulose
dissolves rapidly in the water coming from the liquids that emanate from the wound,
forming a gel on the wound with lled viscosity.
As an additional advantage of the use of olloids, it should be noted that
both pectin and carboxymethylcellulose form a gel with acidic characteristics (pH of
about 4), functioning as a bactericidal agent.
The ve element used may be any conventional adhesive know for such
use, as for example pressure acrylic adhesives, among others. Additionally, such an
adhesive may contain a resin for increasing on, a cohesion increasing agent, an
absorption agent, preferably a polyacrylate superabsorbent, a polyacrylate salt
bsorbent or a e thereof, a plasticizer and optionally a pigment. The
adhesive layer may further be configured in discontinuous patterns, arranged on the
Received by IPONZ 25 June 2012
e of the backing layer in lines, screen, spray or any other pattern which a person
skilled in the art understands to be discontinuous.
FIGS. 1 and 2a illustrate a first embodiment of an adhesive bandage of the
present invention. Adhesive bandage 10 comprises backing layer 20 having first surface
22 and opposing second surface 24 and a core body bounded by first 22 and second 24
surfaces. Adhesive layer 30 is disposed on at least a portion of second surface 24 of
backing layer 20. FIGS. 1 and 2a show adhesive layer 30 disposed on the entirety of
second surface 24 ofbacking layer 20. Absorbent pad 40 is disposed on adhesive layer
such that absorbent pad 40 is associated with, e.g. by ve bonding, backing
layer 20. While adhesive layer 30 is shown covering the entirety of second surface 24
ofbacking layer 20, it is to be understood that the adhesive layer may be disposed on a
portion ofthe second surface of the backing layer, provided that the amount of adhesive
applied, the location of the adhesive layer on the backing layer and the surface area of
the n of the second surface covered by the adhesive layer is sufficient to associate
the absorbent pad to the backing layer, as discussed herein above, and to adhere the
bandage to the skin.
is an embodiment similar to that ed in FIGS. 1 and 2a, except that
the first e of absorbent pad 40 comprises covering layer 43 affixed thereto.
Covering layer 43 is applied to absorbent pad 40 prior to embossing, such that the
network of interconnecting channels is recessed and Visible in ng layer 43.
illustrates a view of absorbent pad 40 as shown in as Viewed
perpendicular to second e 24 of absorbent pad 40. Pad 40 comprises tufted
regions 44 surrounded and ted by a network of interconnecting channels 46
recessed in second surface 42 ofpad 40, thus providing a first embodiment of a
densification pattern, e. g. a hexagon, used in bandages of the present invention.
is a cross—sectional side view of absorbent pad 40 taken along line 3b-—-
3b of Absorbent pad 40 has first surface 41, second surface 42, core body 45, a
plurality of tufted regions 44, and a network of onnecting channels 46 recessed in
second e 42 of pad 40. The thickness (tr) of absorbent pad 40 is defined by the
distance between first 41 and second 42 surfaces of ent pad 40.
Tufted regions 44 have a ess of tt and a substantially m first density.
As shown, first and second surfaces of tufted regions 44 coincide with first 41 and
second 42 surfaces ofpad 40. As such, the thickness ofpad 40 and tufted regions 44 are
Received by IPONZ 25 June 2012
the same. Interconnecting channels 46 have channel sidewalls 47 extending away from
second surface 42 and into core body 45 of absorbent pad 40 and terminating at first
surface 48a of channel base region 48 extending between channel sidewalls 47 .
Channel base regions 48 have a thickness (tc) defined by the distance between first
surface 48a and second surface 48b of base region 48 and a substantially uniform
second density greater than the substantially m first y of tufted regions 44.
As used herein, the terms “low density, intermediate density, and high density” are
relative terms that are used in comparison to each other and unless specifically
quantified herein, are not intended to refer to any specific density or any degree of
density.
is a cross—sectional side View of a second embodiment of an absorbent
pad used in bandages of the present invention. In this embodiment, absorbent pad 80
has first e 81, second surface 82 comprising a covering layer affixed thereto, core
body 85, tufted regions 84, and onnecting channels 86 recessed in second surface
82. The ess (tt) of absorbent pad 80 is defined by the distance between first 81
and second 82 surfaces of absorbent pad 80. Tufted regions 84 have a thickness of tt
and a substantially uniform first y. Interconnecting ls 86 recessed in
second pad surface 82 have channel sidewalls 87 ing away from second pad
surface 82 and into core body 85 of absorbent pad 80 and terminating at first e
883 of channel base region 88 ing between channel sidewalls 87.
Interconnecting channels 83 recessed in first pad surface 81 have channel sidewalls 89
extending away from first pad surface 81 and into core body 85 of absorbent pad 80
and terminating at second surface 88b of channel base region 88 extending between
channel sidewalls 89. Channel base regions 88 have a thickness (tc) defined by the
distance between first 882 and second 88b surfaces of channel base region 88 and a
substantially uniform second density greater than the substantially uniform first density
of tufted regions 84.
FIGS. 4b-4d are embodiments ofbandages of the present invention comprising
absorbent pad 80 depicted in . As shown in , ent pad 80 is
associated to backing layer 90 via adhesive layer 92. Interconnecting channels 83 and
tufted regions 84 are shown, tively. In this embodiment, the network of
interconnected channels 83 may be Visible to the user through second surface 94 of
backing layer 90, for example where g layer 90 is arent or translucent,
Received by IPONZ 25 June 2012
although such Visibility is not required. As shown in , absorbent pad 80 is
ated to backing layer 90 via adhesive layer 92. Channels 83 and tufted s 84
are shown, respectively. In this embodiment, backing layer 90 conforms to recessed
channels 83 such that backing layer 90 includes the network of interconnecting
channels 83 recessed in second surface 94 ing layer 90. As such, the k of
interconnected channels 83 recessed in backing layer 90 is visible to the user.
is a View of the ment depicted in as viewed perpendicular to surface 94
ofbacking layer 90. In this embodiment, the densification pattern formed by tufted
regions 84 and channels 83 is e to the user.
FIGS. 5 and 7 ent additional embodiments ofpad densification patterns of
absorbent pads used in bandages ofthe present invention. In absorbent pad 50
has tufted regions 54 separated by a network of recessed, interconnecting channels 56.
Tufted regions 54 have a diamond shape when viewed perpendicular to the second
surface of the absorbent pad. In ent pad 60 has tufted regions 64
separated by a network ofrecessed, interconnecting channels 66. Tufied regions 64
have a circular shape when viewed perpendicular to the second surface ofthe absorbent
pad.
Though the tufted regions of ent pad ments shown have
hexagonal, diamond, or circular shapes, it is to be understood that the shape of the
tufted regions may be selected from the group consisting of elliptical, ovoid, circular
and polygonal. Polygonal includes shapes which have 4 to 8—sides. Where tufted
regions are polygonal in shape the channels are linear. When tufted regions are
elliptical, ovoid, or circular the channels are non—linear. Though shown as uniform in
FIGS. 3 and 5, the length of the sides of the polygonal tufted region may .
Yet another embodiment of an adhesive bandage of the present invention is
shown in cross—sectional side View in Adhesive bandage 110 comprises backing
layer 120 having a first surface 122 and opposing second surface 124. Adhesive layer
130 is disposed on second e 124 ofbacking layer 120. Intermediate layer 150 is
disposed on adhesive layer 130 so as to achieve bonding between backing layer 120
and intermediate layer 150. Absorbent pad 140 is associated with intermediate layer
150.
Received by IPONZ 25 June 2012
Though shows adhesive layer 130 disposed on the entirety of second
surface 124 ofbacking layer 120, it is to be understood that ve layer 130 may be
disposed on a portion of second surface 124 ofbacking layer 120, as discussed herein
above. Absorbent pad 140 is disposed on a portion of intermediate layer 150 and
ated with intermediate layer 150 so as to e bonding between intermediate
layer 150 and absorbent pad 140, thus also associating pad 140 to g layer 120 via
intermediate layer 150. The bond may be in the form of an adhesive, or may be any
other known means ofbonding, such as by ultrasonic welding. Though shows
absorbent pad 140 disposed on the entirety of intermediate layer 150, it is to be
tood that absorbent pad 140 may be disposed on a portion of intermediate layer
150.
ent pad 140 and intermediate layer 150 may have various shapes, e.g.
rectangular, square, oval, circular, ovoid, oblong, etc, and be sized to cover less area
than backing layer 120 so that, in use, adhesive layer 130 is in contact with the user’s
skin, but preferably does not contact the wound surface.
The absorbent pad may be a fibrous matrix comprising an organized network
selected from the group consisting of threads, yarns, nets, laces, felts and nonwovens. A
preferred method of making the absorbent pad is known to one skilled in the art as the
wet lay process of forming nonwovens.
Embossing may be performed ultrasonically through an ultrasonic system which
includes a nip roll for providing tension to the web, an engrave/machined roll
constructed ofhardened steel, and an ultrasonic horn. The ultrasonic horn and
engrave/machined roll are set to a positioned so that the roll and horn would have no
gap if the material being embossed was not between the rolls. The web would have a
consistent and maintained tension, embossing the web with an ultrasonic system.
atively, embossing may be performed using heat and pressure through a
heated roll system which includes a nip roll for providing tension to the web, an
engrave/machined roll constructed of hardened steel, and an anvil roll. Heat is applied
in this area to raise the ature of the substrate. The anvil roll and
engrave/machined roll are set to a position so that the roll and anvil would have no gap
if the material being ed was not between the rolls. The web would have a
consistent and maintained tension, embossing the web with an engrave/machined roll
and anvil.
Received by IPONZ 25 June 2012
The process of manufacturing the adhesive bandage of the present invention
may be any ofthose conventionally known to produce ve bandages. The backing
layer, absorbent pad, and adhesive layer can be obtained by any s available at
present. For example, an extrusion process may be used for obtaining the backing layer.
In the same way, the adhesive layer can be made in any known manner. A backing
layer as described herein is obtained and an adhesive layer as described herein is
applied to the second surface of the support layer. The ent pad is then associated
with the adhesive bonding layer, thus bonding the absorbent pad to the backing layer.
The adhesive bandages of the invention are y suited to deliver one or more
active ingredients such as therapeutics to the surface of the skin. When ned in the
adhesive bandages ofthe invention, one or more active ients may be contained
primarily or exclusively in the absorbent pad of the adhesive bandage. rative
classes of active ingredients that may be delivered to the skin via the adhesive bandages
of the invention include, but are not limited to, antibiotics, analgesics, retics,
antimicrobials, antiseptics, lergics, anti—acne, anesthetics, anti-inflammatories,
hemostats, cosmetics, vitamins, vasodilators, emollients, pH regulators, antipruritics,
counterirritants, stamines and steroids. Specific active ingredients that may be
delivered to the skin via the dressings of the invention include exidine, neomycin
sulfate, polymyxin—B sulfate, zinc bacitracin, benzalkonium chloride, cetylpyridinium
de, caine, tetracaine, cincaine, lidocaine, benzocaine, silver sulfadiazine,
hydrocortisone, metandienone, trypsin, tolazoline, heparin, pramoxine, aloe vera,
tretinoin, retinol, retinaldehyde, menthol, capsaicin, alpha hydroxy acids and vitamins
such as Vitamin E.
While various embodiments of the invention have been set forth above, it will
be apparent to those skilled in the art that various modifications and variations can be
made in the present invention without departing from the scope or spirit of the
invention. Thus, it is intended that the present ion cover such modifications and
variations as come within the scope of the appended claims and their equivalents.
While not intending to limit the scope of the invention or claims appended to
the specification, the present invention may be better tood with reference to the
following examples.
Received by IPONZ 25 June 2012
EXAMPLE 1: Production of Embossed Pads and Bandages.
Absorbent pads were made from 3.7 oz/yd2 polypropylene (PP) and 3.7 oz/yd2
polyethylene terephthalate (PET) pad stock, respectively. The pads were embossed with
a hexagonal pattern of interconnecting channels. Embossing was performed at slower
and faster speeds. Some of the absorbent pads were then adhered to polyethylene
g layers to form ve bandages. A total of four different pads and four
different bandages were formed.
The thickness of tufted regions (tt), the thickness of the channel base regions (tc)
and the width of the channel base regions (We), were measured optically using a
o PH—A14 Profile tor with a QM—Data 200. Specimens were razor cut
orthogonally to the hexagonal pattern. Five measurements were taken for each of the
four different pads and four different es formed. The depth of the channel base
regions (he) were calculated based upon the thickness of the tufted and channel base
regions.
Table 1 shows the maximum and minimum thickness of tufted regions (tt), the
maximum and minimum thickness ofthe channel base regions (tc), the width of the
l base regions (we), and the depth of the channel base regions (he).
Table 1: Dimensions ofEmbossed Pads and Bandages.
Material Min t. Max tc Min t. Max 1. h.
(mm) (mm) (mm) (mm) 1 w.(mm) ‘ (mm)
PP Pad (slow) 1.004 1.080 1.570 1.967
PP Pad (fast) 1.092 1.204 1.228 1.296
PET Pad 0.149 0.192 0.927 1.253
(slow)
PET Pad 0.824 0.916 0.918 1.293
(fast)
PP Bandage 0.268 0.306 0.804 0.993
(slow)
PP Bandage 0.701 0.884 1.064 1.470
(fast) ‘ 0.3560 ' 0.769
PET Bandage 0.142 0.152 1.119 1.309
(slow) [0.302 ' 1.167
PET Bandage 1.165 1.097 1.133 .323 0.205
(fast) “I
.__..L_—..__.
Received by IPONZ 25 June 2012
EXAMPLE 2: Fluid Absorption of Embossed and Non-Embossed Pads:
ent 1 inch by 1 inch pads were made from 3.7 02/de polypropylene (PP)
non-woven pad stock and 3.7 02/de polyethylene terephthalate (PET) non-woven pad
stock, as in Example 1. Some absorbent pads were embossed at a speed intermediate to
those of Example 1 with a hexagonal pattern of onnecting channels for testing. A
total of four different pads were tested.
Each pad was placed over a SOuL drop of synthetic blood having viscosity less
than 50,000 centipoise. A glass slide and weight (200 grams) were placed on each pad
for 10 seconds. After 3 minutes, the blood spread area was then measured using image
analysis and recorded as the percentage of the pad area. Three specimens were
measured for each sample.
Table 2 shows the spread area for pads having a network of interconnecting
channels embossed into the surface versus bossed pads.
Table 2: Fluid Spread Area.
PP embossed 48 O 2
PET non-embossed 32 | 21
PET embossed 47 t 7.2 ‘
The table shows that embossing ent pads according to the present
invention significantly increases the spread area ofthe synthetic blood.
EXAMPLE 3: Ointment Spread of Embossed and Non-Embossed Pads.
ent pads made according to Example 2 were tested for Ointment Spread
as described below.
A tinted anti-bacterial ointment (0.1 g) was placed on each pad. A glass slide
and weight (200 grams) were placed on each pad for 10 seconds. The ointment spread
area was then measured using image is and recorded as the tage of the pad
area. Three specimens were measured for each sample.
Table 3 shows the spread area for pads having a network of interconnecting
channels embossed into the surface versus non-embossed pads.
Table 3: Ointment Spread Area.
Received by IPONZ 25 June 2012
en Spread Area % Std. Dev.
PP non-embossed
PP embossed —I_
PET non-embossed —E_
The table shows that embossing absorbent pads ing to the present
invention significantly decreases the spread area of the tinted ointment.
EXAMPLE 4: Fluid Absorption of ed and bossed Pads on
Adhesive Bandages.
Absorbent pads made according to Example 2 were placed on a polyethylene
laminate backing layer comprising a pressure sensitive adhesive applied thereto. The
bandages were tested for fluid absorption as described below.
Each bandage was placed over a 30uL drop of synthetic blood. A glass slide
and weight (200 grams) were placed on each bandage for 10 seconds. After 3 s,
the blood spread area was then measured using image analysis and recorded as the
percentage of the bandage area. Three specimens were measured for each sample and
compared to a comparative bandage that did not include a pad having a network of
interconnecting channels embossed therein. Table 4 shows the spread area for adhesive
bandages according to the present invention versus comparative es that do not
include a pad having a network of interconnecting channels embossed therein.
Table 4: Fluid Spread area.
Specimen I Spread Area % I Std. Dev.
Control Bandage with non-embossed Pad I 27 I 1.6
Bandage with PET Embossed Pad I 68 I 3.1
Bandage with PP Embossed Pad I 78 I 5.3
The table shows that embossing absorbent pads on adhesive bandages according
to the present invention significantly increases the spread area of the synthetic blood
ed to the comparative bandage.
ed by IPONZ 25 June 2012
EXAMPLE 5: Ointment Spread of Embossed and Non—Embossed Pads on
Adhesive Bandages.
Absorbent pads made according to Example 2 were placed on a polyethylene
laminate backing layer comprising a pressure sensitive adhesive applied thereto. The
es were tested for nt spread area as described below.
A tinted anti-bacterial ointment (0.05g) was placed on each bandage. A glass
slide and weight (200 grams) were placed on each bandage for 10 seconds. The
ointment spread area was then measured using image analysis, and recorded as the
percentage ofthe pad area. Three specimens were measured for each sample and
compared to a comparative bandage that did not include a pad having a network of
onnecting channels embossed therein. Table 5 shows the spread area for adhesive
bandages according to the present invention versus comparative adhesive bandages
utilizing pads that do not have a network of interconnecting channels embossed therein.
Table 5: Ointment Spread Area.
Spread Area % Std Dev
Control Bandage with non-embossed Pad —_
e with PET Embossed Pad
Bandage with PP Embossed Pad ] 26
The table shows that ing pads on bandages according to the t
invention significantly decreases the spread area of the tinted ointment versus the
comparative adhesive bandage that does not include a pad having a k of
interconnecting channels embossed therein.
ed by IPONZ 25 June 2012
Claims (19)
1. An adhesive bandage for application to abrasions or cuts in the skin, comprising: a backing layer comprising a first surface and a second surface opposite said first surface; an adhesive layer applied to at least a n of said second surface of said backing layer; and an absorbent pad associated with said backing layer, said absorbent pad sing, a first surface facing said second surface of said backing layer and having a 10 first surface area, a second surface opposite said first surface and having a second surface area; and a core body bounded by said first and second surfaces; said absorbent pad comprising a plurality of tufted regions surrounded and 15 separated by a first network of interconnecting channels recessed in said second surface of said absorbent pad, said channels comprising channel sidewalls extending away from said second e of said absorbent pad and into said core body of said absorbent pad and terminating in a first surface of a channel base region extending n said channel sidewalls; 20 wherein the absorbent pad is free of slits or perforations uniformly distributed throughout the absorbent pad that would allow the adhesive layer to contact the wound surface; wherein said tufted regions have a ntially uniform first density, said channel base region has a substantially uniform second density greater than said substantially 25 uniform first density of said tufied regions and said network of onnecting channels is e; and with the proviso that the shape of each of the tufted regions is not a polygon having from four to eight sides.
2. The bandage of claim 1 wherein said second y of said channel base region 30 is about 12 times or less greater than said first density of said tufted regions. Received by IPONZ 25 June 2012
3. The bandage of claim 1 wherein said substantially uniform second density of said channel base region is from about 0.11 g/cc to about 0.96 g/cc.
4. The bandage of claim 1 wherein said ntially uniform first density of said tufted regions is from about 0.082 g/cc to about 0.17 g/cc.
5. The bandage of claim 1 wherein said channels have a width of from about 0.2 to about 0.6 millimeters and a depth from about 0.02 to about 2 millimeters. 10
6. The bandage of claim 1 n said absorbable pad is not degradable in water.
7. The bandage of claim 1 wherein said first k of interconnecting channels comprises from about 5 to about 20 percent of said second surface area of said second surface of said absorbent pad.
8. The bandage of claim 1 wherein said absorbent pad comprises fibers selected from the group consisting of l and synthetic materials.
9. The bandage of claim 1 further comprising an intermediate layer disposed 20 between said g layer and said absorbent pad.
10. The bandage of claim 1 wherein the shape of said tufted regions is selected from the group consisting ofpolygonal, elliptical, ovoid and circular. 25
11. The bandage of claim 1 wherein said channels are non-linear and the shape of said tufted regions is selected from the group consisting of elliptical, ovoid and circular.
12. The e of claim ll wherein said channels are linear and the shape of said tufted regions is polygonal.
13. The e of claim 1 r comprising a second network of interconnecting channels recessed in said first surface of said absorbent pad, said tufted regions being surrounded and separated by said second network of interconnecting channels recessed Received by IPONZ 25 June 2012 in said first surface of said absorbent pad, said channels in said second network of interconnecting ls comprising channel sidewalls extending away from said first surface and into said core body of said absorbent pad and terminating in a second surface of said channel base region te said first surface of said channel base region and extending between said channel sidewalls of said second network.
14. The bandage of claim 1 wherein said thickness of said absorbent pad is from about 0.3 eters to about 2.5 millimeters. 10
15. The bandage of claim 1 n the thickness of said base channel region is from about 0.1 millimeters to about 1.5 millimeters.
16. The bandage of claim 13 n said second network of interconnecting channels is visible.
17. The bandage of claim 1 wherein said second surface of said absorbent pad comprises a covering layer.
18. The bandage of claim 13 wherein said second surface of said absorbent pad 20 comprises a covering layer.
19. A bandage according to claim 1 substantially as herein described with reference to any e thereof and/or any embodiment shown in the accompanying figures. ed by IPONZ 25 June 2012
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/036,471 | 2011-02-28 | ||
US13/036,471 US20120220973A1 (en) | 2011-02-28 | 2011-02-28 | Adhesive bandage |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ598438A NZ598438A (en) | 2012-08-31 |
NZ598438B true NZ598438B (en) | 2012-12-11 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2012201127B2 (en) | Adhesive bandage | |
AU2012201128B2 (en) | Adhesive bandage | |
US8058499B2 (en) | Absorbent wound dressing containing a hydrogel layer | |
JP4633415B2 (en) | Absorbent article and manufacturing method thereof | |
AU782939B2 (en) | Microporous films comprising flocked fibers | |
US20110077608A1 (en) | Cushioned adhesive bandage | |
EP3288510B1 (en) | Wound dressing | |
CN102137684A (en) | Haemostatic material | |
EP3288512B1 (en) | Wound dressing | |
US20170128270A1 (en) | Wound dressing | |
NZ598438B (en) | Adhesive bandage | |
NZ598439B (en) | Adhesive bandage |